Peripheral Vasoconstrictors has 1 known drug interaction based on U.S. FDA drug labeling data. Of these, 1 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Dihydroergotamine Mesylate. Patients taking Peripheral Vasoconstrictors should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 1
- Contraindicated
- 1
Contraindicated (1)
- Peripheral Vasoconstrictors + Dihydroergotamine Mesylate— Should not be used together; combination may cause synergistic elevation of blood pressure.